Literature DB >> 18640393

Determinants of leukocyte adenosine triphosphate-binding cassette transporter G1 gene expression in type 2 diabetes mellitus.

Huali Zhou1, Kathryn C B Tan, Sammy W M Shiu, Ying Wong.   

Abstract

Cellular cholesterol efflux is regulated by cholesterol transporters including adenosine triphosphate-binding cassette transporter A1 (ABCA1), ABCG1, and scavenger receptor class B type I (SR-BI). We have investigated whether the expression of these transporters is affected by type 2 diabetes mellitus and the association with glycemic indexes and oxidized low-density lipoprotein (oxLDL). Messenger RNA of ABCA1, ABCG1, and SR-BI in peripheral monocytes was measured in 30 diabetic patients and 30 matched controls. Plasma oxLDL and advanced glycation end products (AGEs) were assayed by enzyme-linked immunosorbent assay. Cellular cholesterol efflux from monocytes to serum was determined in a subgroup chosen randomly. The expression of ABCG1 was decreased in diabetic patients (P < .05), whereas the levels of ABCA1 and SR-BI were comparable between the 2 groups. Fasting glucose, hemoglobin A(1c), AGEs, and oxLDL were all significantly increased in diabetic patients. There was an inverse correlation between serum AGEs and ABCG1 (r = -0.44, P < .05) that remained significant after adjusting for potential confounding factors. No associations between fasting glucose, hemoglobin A(1c), plasma lipids, or oxLDL and the expression of ABCG1, ABCA1, or SR-BI were found. Cholesterol efflux from monocytes to standard serum or autologous serum was significantly impaired in diabetic patients, and the reduction in efflux to autologous serum correlated with the expression of ABCG1 (r = 0.60, P < .05). The expression of ABCG1 in monocytes is reduced in type 2 diabetes mellitus and is partly related to serum AGEs concentration. The reduction in ABCG1 is associated with impairment in cholesterol efflux and may contribute to accelerated foam cell formation in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18640393     DOI: 10.1016/j.metabol.2008.03.020

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  9 in total

Review 1.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

2.  The transcription levels of ABCA1, ABCG1 and SR-BI are negatively associated with plasma CRP in Chinese populations with various risk factors for atherosclerosis.

Authors:  Chengjiang Li; Renyong Guo; Juanya Lou; Huali Zhou
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

3.  The ABCs of sterol transport.

Authors:  Angel Baldán; Dragana D Bojanic; Peter A Edwards
Journal:  J Lipid Res       Date:  2008-11-06       Impact factor: 5.922

4.  Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys.

Authors:  Chongren Tang; Jenny E Kanter; Karin E Bornfeldt; Renee C Leboeuf; John F Oram
Journal:  J Lipid Res       Date:  2009-11-23       Impact factor: 5.922

5.  Linoleic acid suppresses cholesterol efflux and ATP-binding cassette transporters in murine bone marrow-derived macrophages.

Authors:  Nicole L Spartano; Stefania Lamon-Fava; Nirupa R Matthan; Martin S Obin; Andrew S Greenberg; Alice H Lichtenstein
Journal:  Lipids       Date:  2014-03-05       Impact factor: 1.880

Review 6.  Emerging new paradigms for ABCG transporters.

Authors:  Paul T Tarr; Elizabeth J Tarling; Dragana D Bojanic; Peter A Edwards; Angel Baldán
Journal:  Biochim Biophys Acta       Date:  2009-01-22

7.  Regulation of ATP-binding cassette transporters and cholesterol efflux by glucose in primary human monocytes and murine bone marrow-derived macrophages.

Authors:  N L Spartano; S Lamon-Fava; N R Matthan; J Ronxhi; A S Greenberg; M S Obin; A H Lichtenstein
Journal:  Exp Clin Endocrinol Diabetes       Date:  2014-05-16       Impact factor: 2.949

8.  Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function.

Authors:  Dipesh C Patel; Christiane Albrecht; Darrell Pavitt; Vijay Paul; Celine Pourreyron; Simon P Newman; Ian F Godsland; Jonathan Valabhji; Desmond G Johnston
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

9.  Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus-Brief Report.

Authors:  Johanna Apro; Uwe J F Tietge; Arne Dikkers; Paolo Parini; Bo Angelin; Mats Rudling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-31       Impact factor: 8.311

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.